Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

L. Trodella; Lucio Trodella; R. M. D'Angelillo; Rolando Maria D'Angelillo; S. Ramella; Sara Ramella; F. Cellini; Numa Cellini; M. Ciresa; Marzia Ciresa; Alfredo Cesario; Pierluigi Granone

doi:10.1093/annonc/mdj950

Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

L. Trodella, Lucio Trodella, R. M. D'Angelillo, Rolando Maria D'Angelillo, S. Ramella, Sara Ramella, F. Cellini, Numa Cellini, M. Ciresa, Marzia Ciresa, Alfredo Cesario, Pierluigi Granone

Università Cattolica del Sacro Cuore

Universita Campus Bio-Medico di Roma

Risultato della ricerca: Contributo in rivista › Articolo

5 Citazioni (Scopus)

Abstract

Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.

Lingua originale	Inglese
pagine (da-a)	52-54
Numero di pagine	3
Rivista	Annals of Oncology
Volume	17
DOI	https://doi.org/10.1093/annonc/mdj950
Stato di pubblicazione	Pubblicato - 2006

Keywords

lung cancer

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/annonc/mdj950

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{a07c9b3032b84751992b0c2f3811cf4d,

title = "Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.",

abstract = "Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.",

keywords = "lung cancer, lung cancer",

author = "L. Trodella and Lucio Trodella and D'Angelillo, \{R. M.\} and D'Angelillo, \{Rolando Maria\} and S. Ramella and Sara Ramella and F. Cellini and Numa Cellini and M. Ciresa and Marzia Ciresa and Alfredo Cesario and Pierluigi Granone",

year = "2006",

doi = "10.1093/annonc/mdj950",

language = "English",

volume = "17",

pages = "52--54",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

AU - Trodella, L.

AU - Trodella, Lucio

AU - D'Angelillo, R. M.

AU - D'Angelillo, Rolando Maria

AU - Ramella, S.

AU - Ramella, Sara

AU - Cellini, F.

AU - Cellini, Numa

AU - Ciresa, M.

AU - Ciresa, Marzia

AU - Cesario, Alfredo

AU - Granone, Pierluigi

PY - 2006

Y1 - 2006

N2 - Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.

AB - Gemcitabine (2'-2'-difluorodeoxycytidine) is a well-known cytotoxic drug and a potent radio-enhancer. We herein report the in vitro evidence of its activity, and the clinical experiences when this drug is administered concurrently with radiation. The phase I-II trials are analyzed, focusing on the recent ability to deliver irradiation with low incidence of side effects.

KW - lung cancer

UR - http://hdl.handle.net/10807/5497

U2 - 10.1093/annonc/mdj950

DO - 10.1093/annonc/mdj950

M3 - Article

SN - 0923-7534

VL - 17

SP - 52

EP - 54

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo